113 related articles for article (PubMed ID: 20945534)
1. Botswana gets boost in AIDS funding.
AIDS Patient Care STDS; 2010 Oct; 24(10):685. PubMed ID: 20945534
[No Abstract] [Full Text] [Related]
2. Public-private partnerships and antiretroviral drugs for HIV/AIDS: lessons from Botswana.
Ramiah I; Reich MR
Health Aff (Millwood); 2005; 24(2):545-51. PubMed ID: 15757942
[TBL] [Abstract][Full Text] [Related]
3. Secure the future. Care and support for women and children with HIV/AIDS. Evaluation Report. May 6, 1999 - December 31, 2000.
International Association of Physicians in AIDS Care
IAPAC Mon; 2001 Nov; 7(11):R1-20. PubMed ID: 11799952
[No Abstract] [Full Text] [Related]
4. HIV/AIDS. Botswana's success comes at steep cost.
Cohen J
Science; 2008 Jul; 321(5888):526-9. PubMed ID: 18653882
[No Abstract] [Full Text] [Related]
5. Public-private partnerships in health care for developing countries: a new paradigm for change.
Ahn M; Herman A; Damonti J
Manag Care Q; 2000; 8(4):65-72. PubMed ID: 11146847
[TBL] [Abstract][Full Text] [Related]
6. Building effective public-private partnerships: experiences and lessons from the African Comprehensive HIV/AIDS Partnerships (ACHAP).
Ramiah I; Reich MR
Soc Sci Med; 2006 Jul; 63(2):397-408. PubMed ID: 16487640
[TBL] [Abstract][Full Text] [Related]
7. Fundraising 101: why seek private funding?
Duyck GP
J Public Health Manag Pract; 2008; 14(2):199-201. PubMed ID: 18287928
[No Abstract] [Full Text] [Related]
8. HIV/AIDS. The high cost of stolen funds.
Cohen J
Science; 2008 Jul; 321(5888):523. PubMed ID: 18653880
[No Abstract] [Full Text] [Related]
9. AIDS research. Drug trials without the drugs?
Cohen J
Science; 2003 May; 300(5623):1212-3. PubMed ID: 12764159
[No Abstract] [Full Text] [Related]
10. Cooperation forms to accelerate access to AIDS care in developing countries.
AIDS Read; 2000 Jun; 10(6):339. PubMed ID: 10881360
[No Abstract] [Full Text] [Related]
11. An unequal activism for an unequal epidemic?
Selemogo M
Dev World Bioeth; 2005 May; 5(2):153-68. PubMed ID: 15842724
[TBL] [Abstract][Full Text] [Related]
12. Initial lessons from public-private partnerships in drug and vaccine development.
Wheeler C; Berkley S
Bull World Health Organ; 2001; 79(8):728-34. PubMed ID: 11545329
[TBL] [Abstract][Full Text] [Related]
13. Company, academics argue over data.
Niiler E
Nat Biotechnol; 2000 Dec; 18(12):1235. PubMed ID: 11101790
[No Abstract] [Full Text] [Related]
14. New public/private sector effort initiated to accelerate access to HIV/AIDS care and treatment in developing countries.
Int J Epidemiol; 2000 Oct; 29(5):956. PubMed ID: 11034986
[No Abstract] [Full Text] [Related]
15. Botswana--the challenges of fighting HIV/AIDS.
Vázquez E
Posit Aware; 2003; 14(6):23-4. PubMed ID: 14743789
[No Abstract] [Full Text] [Related]
16. "New dawn" for Botswana: offering free HIV treatment--and hope. Interview with Ernest Darkoh, MD, MPH.
Darkoh E
JAMA; 2004 Dec; 292(21):2565. PubMed ID: 15572701
[No Abstract] [Full Text] [Related]
17. HIV/AIDS. The great funding surge.
Cohen J
Science; 2008 Jul; 321(5888):512-9. PubMed ID: 18653876
[No Abstract] [Full Text] [Related]
18. [Biomedical research: private interests and public interests].
Martin J
Sante Publique; 2001 Mar; 13(1):89-93. PubMed ID: 11525046
[No Abstract] [Full Text] [Related]
19. Global AIDS fund plans to triple growth in services.
AIDS Policy Law; 2007 May; 22(10):2. PubMed ID: 17632836
[No Abstract] [Full Text] [Related]
20. Commentary: the reality of treating HIV and AIDS in poor countries.
Sykes R
BMJ; 2002 Jan; 324(7331):216-7. PubMed ID: 11831203
[No Abstract] [Full Text] [Related]
[Next] [New Search]
